Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)
23.05
+0.55 (2.44%)
Jan 23, 2026, 3:00 PM CST
SHA:688687 Revenue
Beijing Kawin Technology Share-Holding had revenue of 360.40M CNY in the quarter ending September 30, 2025, a decrease of -12.95%. This brings the company's revenue in the last twelve months to 1.15B, down -21.13% year-over-year. In the year 2024, Beijing Kawin Technology Share-Holding had annual revenue of 1.23B, down -12.87%.
Revenue (ttm)
1.15B
Revenue Growth
-21.13%
P/S Ratio
3.37
Revenue / Employee
1.91M
Employees
600
Market Cap
3.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.23B | -181.71M | -12.87% |
| Dec 31, 2023 | 1.41B | 252.03M | 21.73% |
| Dec 31, 2022 | 1.16B | 15.62M | 1.36% |
| Dec 31, 2021 | 1.14B | 282.30M | 32.75% |
| Dec 31, 2020 | 862.05M | 37.13M | 4.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.69B |
| Qingdao Vland Biotech INC. | 1.39B |
| Guangdong VTR Bio-Tech | 830.87M |
| Boji Medical Technology | 770.19M |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Shanghai Model Organisms Center | 419.09M |
| Yantai Zhenghai Biotechnology | 347.60M |
| Shanghai Shen Lian Biomedical | 292.81M |